Correlation Between Abcellera Biologics and Virios Therapeutics

Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Virios Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Virios Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abcellera Biologics and Virios Therapeutics Llc, you can compare the effects of market volatilities on Abcellera Biologics and Virios Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Virios Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Virios Therapeutics.

Diversification Opportunities for Abcellera Biologics and Virios Therapeutics

-0.29

Correlation Coefficient

Abcellera Biologics  Virios Therapeutics

Very good diversification

The 3 months correlation between Abcellera and Virios is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Virios Therapeutics Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virios Therapeutics Llc and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Virios Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virios Therapeutics Llc has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Virios Therapeutics go up and down completely randomly.

Pair Corralation between Abcellera Biologics and Virios Therapeutics

Given the investment horizon of 90 days Abcellera Biologics is expected to generate 2.81 times less return on investment than Virios Therapeutics. But when comparing it to its historical volatility, Abcellera Biologics is 3.05 times less risky than Virios Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Virios Therapeutics Llc is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  449.00  in Virios Therapeutics Llc on August 13, 2024 and sell it today you would lose (54.00) from holding Virios Therapeutics Llc or give up 12.03% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	78.13%
Values	Daily Returns

Abcellera Biologics  vs.  Virios Therapeutics Llc

Abcellera Biologics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent fundamental indicators, Abcellera Biologics is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Virios Therapeutics Llc

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Virios Therapeutics Llc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly uncertain basic indicators, Virios Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Abcellera Biologics and Virios Therapeutics

The main advantage of trading using opposite Abcellera Biologics and Virios Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Virios Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virios Therapeutics will offset losses from the drop in Virios Therapeutics' long position.

The idea behind Abcellera Biologics and Virios Therapeutics Llc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.